LA JOLLA PHARMACEUTICAL CO Mergers & Acquisitions Contracts & Agreements
7 Contracts & Agreements
- Merger Agreements (7 contracts)
- Agreement and Plan of Merger by and among the Parent, the Purchaser and the Company, dated as of July 10, 2022 (Filed With SEC on July 11, 2022)
- Form of Exchange Agreement, dated June 24, 2020, by and among La Jolla, Merger Sub and the holder named therein (Filed With SEC on June 24, 2020)
- Form of Support Agreement, dated June 24, 2020, by and among La Jolla, Merger Sub and the stockholder named therein (Filed With SEC on June 24, 2020)
- Agreement and Plan of Merger by and among the La Jolla, Merger Sub and Tetraphase, dated June 24, 2020 (Filed With SEC on June 24, 2020)
- AGREEMENT AND PLAN OF MERGER OF LA JOLLA PHARMACEUTICAL COMPANY, ADELAWARE CORPORATION AND LJPC MERGER SUB, INC., A CALIFORNIA CORPORATION (Filed With SEC on June 20, 2012)
- VIA FACSIMILE AND EMAIL March 3, 2010 Adamis Pharmaceutical Corporation 2658 Del Mar Heights Road, #555 Del Mar, California 92014 Attention: President Re: Termination of Merger... (Filed With SEC on March 5, 2010)
- AGREEMENT AND PLAN OF REORGANIZATION among LA JOLLA PHARMACEUTICAL COMPANY a Delaware corporation, JEWEL MERGER SUB, INC., a Delaware corporation and ADAMIS PHARMACEUTICALS... (Filed With SEC on December 7, 2009)
